ID21224A - Metode pembuatan obat yang mengandung protein plasma - Google Patents

Metode pembuatan obat yang mengandung protein plasma

Info

Publication number
ID21224A
ID21224A IDW990038A ID990038A ID21224A ID 21224 A ID21224 A ID 21224A ID W990038 A IDW990038 A ID W990038A ID 990038 A ID990038 A ID 990038A ID 21224 A ID21224 A ID 21224A
Authority
ID
Indonesia
Prior art keywords
plasma
protein
medicament
citrate
containing protein
Prior art date
Application number
IDW990038A
Other languages
English (en)
Indonesian (id)
Inventor
Wolfgang Teschner
Yendra Linnau
Sonja Svatos
Herwig Igel
Original Assignee
Immuno Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=3517640&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ID21224(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Immuno Ag filed Critical Immuno Ag
Publication of ID21224A publication Critical patent/ID21224A/id

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/16—Blood plasma; Blood serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/76—Albumins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Toxicology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Developmental Biology & Embryology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IDW990038A 1996-09-16 1997-09-10 Metode pembuatan obat yang mengandung protein plasma ID21224A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AT0163396A AT403989B (de) 1996-09-16 1996-09-16 Verfahren zur herstellung eines plasmaprotein-hältigen arzneimittels

Publications (1)

Publication Number Publication Date
ID21224A true ID21224A (id) 1999-05-06

Family

ID=3517640

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW990038A ID21224A (id) 1996-09-16 1997-09-10 Metode pembuatan obat yang mengandung protein plasma

Country Status (24)

Country Link
US (3) US20020034809A1 (hu)
EP (1) EP0927195B1 (hu)
JP (1) JP2001500867A (hu)
KR (1) KR20000036002A (hu)
CN (1) CN1230967A (hu)
AR (1) AR009582A1 (hu)
AT (2) AT403989B (hu)
AU (1) AU732519B2 (hu)
BR (1) BR9712044A (hu)
CA (1) CA2265936C (hu)
CZ (1) CZ91199A3 (hu)
DE (1) DE59710700D1 (hu)
DK (1) DK0927195T3 (hu)
ES (1) ES2206701T3 (hu)
HU (1) HUP0002265A3 (hu)
ID (1) ID21224A (hu)
IL (1) IL128770A0 (hu)
IN (1) IN187314B (hu)
MX (1) MXPA99002144A (hu)
NO (1) NO991198L (hu)
PL (1) PL332159A1 (hu)
PT (1) PT927195E (hu)
SK (1) SK32899A3 (hu)
WO (1) WO1998012225A2 (hu)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2103236B1 (es) * 1996-01-30 1998-04-16 Grifols Grupo Sa Albumina humana terapeutica con baja capacidad para la fijacion de aluminio.
AT407484B (de) * 1997-11-12 2001-03-26 Bio Prod & Bio Eng Ag Arzneimittel zur förderung der wundheilung
AT408946B (de) * 1999-02-18 2002-04-25 Immuno Ag Verwendung von orosomucoid zur herstellung einer pharmazeutischen präparation
JP2003040798A (ja) * 2001-07-26 2003-02-13 Nihon Pharmaceutical Co Ltd 低アルミニウム含有アルブミン製剤およびその製造法
IL162239A0 (en) 2001-12-21 2005-11-20 Novo Nordisk Healthcare Ag Liquid composition of factor vii polypeptides
AT501088A2 (de) * 2002-12-18 2006-06-15 Bio Prod & Bio Eng Ag Stabile therapeutische proteine
US7897734B2 (en) 2003-03-26 2011-03-01 Novo Nordisk Healthcare Ag Method for the production of proteins
CA2525224A1 (en) * 2003-05-23 2004-12-02 Michael Bech Jensen Protein stabilization in solution
ES2574581T3 (es) 2003-08-14 2016-06-20 Novo Nordisk Health Care Ag Composición farmacéutica líquida acuosa de polipéptidos de tipo Factor VII
ES2294976B1 (es) * 2007-11-12 2008-12-16 Grifols, S.A. "procedimiento de obtencion de albumina humana de alta eficacia para su uso en terapia de detoxificacion".
RU2624139C2 (ru) 2011-12-05 2017-06-30 Фэктор Байосайенс Инк. Способы и препараты для трансфекции клеток
ES2381828B1 (es) * 2012-03-20 2012-11-16 Grifols, S.A. PROCEDIMIENTO PARA OBTENER UNA COMPOSICION DE IgG MEDIANTE TRATAMIENTO TERMICO
CA3067735A1 (en) 2017-08-17 2019-02-21 Just Biotherapeutics, Inc. Method of purifying glycosylated protein from host cell galectins and other contaminants

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE384134C (de) * 1921-05-07 1923-10-25 Chemisch Pharmazeutische Werke Verfahren zur Herstellung eines Kamillenextraktes
DE2331854A1 (de) * 1973-06-22 1975-01-16 Greither Salus Haus Dr Otto Verfahren zur herstellung standardisierter arzneimittel aus kamillenblueten
FR2630115B1 (fr) * 1988-04-14 1994-10-28 Merieux Inst Procede de stabilisation des solutions d'albumine humaine et solution obtenue
SE500110C2 (sv) * 1989-06-27 1994-04-18 Kabi Pharmacia Ab Sätt att rena ett protein från därtill bundna flervärda metalljoner
US5250663A (en) * 1990-04-19 1993-10-05 Miles Inc. Preparing essentially monomeric normal human serum albumin
JP2949846B2 (ja) * 1990-11-30 1999-09-20 吉富製薬株式会社 アルブミン製剤の保存方法
US5561115A (en) * 1994-08-10 1996-10-01 Bayer Corporation Low temperature albumin fractionation using sodium caprylate as a partitioning agent
ES2103236B1 (es) * 1996-01-30 1998-04-16 Grifols Grupo Sa Albumina humana terapeutica con baja capacidad para la fijacion de aluminio.
US5744586A (en) * 1996-06-26 1998-04-28 Alpha Therapeutic Corporation Manufacturing process for the production of purified transferrin
US5886154A (en) 1997-06-20 1999-03-23 Lebing; Wytold R. Chromatographic method for high yield purification and viral inactivation of antibodies

Also Published As

Publication number Publication date
CA2265936C (en) 2008-04-22
AR009582A1 (es) 2000-04-26
IN187314B (hu) 2002-03-23
EP0927195A2 (de) 1999-07-07
EP0927195B1 (de) 2003-09-03
WO1998012225A3 (de) 1998-04-23
WO1998012225A2 (de) 1998-03-26
KR20000036002A (ko) 2000-06-26
US20050249815A1 (en) 2005-11-10
ATA163396A (de) 1997-12-15
BR9712044A (pt) 1999-08-24
NO991198D0 (no) 1999-03-11
AU732519B2 (en) 2001-04-26
CZ91199A3 (cs) 1999-06-16
SK32899A3 (en) 1999-08-06
ES2206701T3 (es) 2004-05-16
CN1230967A (zh) 1999-10-06
US20020034809A1 (en) 2002-03-21
ATE248857T1 (de) 2003-09-15
DE59710700D1 (de) 2003-10-09
PT927195E (pt) 2004-01-30
AT403989B (de) 1998-07-27
IL128770A0 (en) 2000-01-31
JP2001500867A (ja) 2001-01-23
CA2265936A1 (en) 1998-03-26
PL332159A1 (en) 1999-08-30
US20140234292A1 (en) 2014-08-21
US8709492B2 (en) 2014-04-29
HUP0002265A3 (en) 2003-01-28
HUP0002265A2 (hu) 2000-11-28
NO991198L (no) 1999-05-14
AU4289997A (en) 1998-04-14
DK0927195T3 (da) 2003-11-24
MXPA99002144A (es) 2005-04-28

Similar Documents

Publication Publication Date Title
ID21224A (id) Metode pembuatan obat yang mengandung protein plasma
EE200300578A (et) Plasmi(i)n(ogeeni) eemaldamine valgulahustest
AU2001232735A1 (en) Process for solubilizing glucagon-like peptide 1 compounds
DE69311130D1 (de) Arylpropionsäurederivat, verfahren zu seiner herstellung und seine verwendung als analgetikum
ATE323759T1 (de) Rückgewinnung eines proteins bei hohem ph-wert
ATE203907T1 (de) Dermatologische zubereitung zur behandlung von aktinischen keratosen
DE59609824D1 (de) Verfahren zur herstellung von substituierten arylmilchsäure-haltigen cyclodepsipeptiden mit 24 ringatomen
PL328712A1 (en) Anionic salts of non-narcotic analgetic agents of carboxylic acid type combined with morphine and diamorphine, method of obtaining them, their application and pharmaceutic agents containing such salts
DE69403210D1 (de) Verfahren zur herstellung von n-acetylneuraminsäure
DK0840792T3 (da) (S)-hydroxynitrillyase fra Hevea brasiliensis
AU4876196A (en) A process for the preparation of factor ix from biological sources
DE60126802D1 (de) Cyclopeptide, verfahren zu ihrer herstellung und ihre verwendung zur hemmung oder stimulierung von angiogenese
DE69523038D1 (de) Verfahren zur herstellung von hiv proteasinhibitoren
DE60123125D1 (de) Verfahren zur herstellung von 1-(aminomethyl) cyclohexanessigsäure
SE9902364D0 (sv) New process
FI950094A0 (fi) Menetelmä vesipohjaisen entsyymiliuoksen puhdistamiseksi
NO308596B1 (no) FremgangsmÕte for fremstilling av faste, frittflytende vannløselige salter av aryloksy-C1-C4-alkankarboksylsyrer
DE69613685D1 (de) D-aminosäure-oxidase kodierendes dns-fragment
ATE202146T1 (de) Verbesserte enzymatische kupplungsreaktion von n- geschützte l-asparaginsäure und phenylalaninmethylester
ATE348840T1 (de) Verfahren zur prävention einer durch gefrieren induzierten abnahme der aktivität eines proteins
KR910006477A (ko) 플라스미노겐 활성화제-엑제제 2(pai-2)의 정제방법
WO2003060118A1 (fr) Proteine fer-soufre, complexe proteine-fad, transporteur d'electrons, et procede de mesure de l'inhibition de l'activite de ferredoxine
UA23098A (uk) Спосіб приготуваhhя морфологічhих препаратів для імуhоцитохімічhого досліджеhhя